<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Mariniello K</submitter><funding>NIDDK NIH HHS</funding><funding>Biotechnology and Biological Sciences Research Council</funding><pubmed_abstract>Disruption of processes involved in tissue development and homeostatic self-renewal is increasingly implicated in cancer initiation, progression, and recurrence. The adrenal cortex is a dynamic tissue that undergoes life-long turnover. Here, using genetic fate mapping and murine adrenocortical carcinoma (ACC) models, we have identified a population of adrenocortical stem cells that express delta-like non-canonical Notch ligand 1 (DLK1). These cells are active during development, near dormant postnatally but are re-expressed in ACC. In a study of over 200 human ACC samples, we have shown DLK1 expression is ubiquitous and is an independent prognostic marker of recurrence-free survival. Paradoxically, despite its progenitor role, spatial transcriptomic analysis has identified DLK1 expressing </pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2024.08.22.609117</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11370565</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.</pubmed_title><pmcid>PMC11370565</pmcid><funding_grant_id>BB/V007246/1</funding_grant_id><funding_grant_id>R01 DK123694</funding_grant_id><pubmed_authors>Tamburello M</pubmed_authors><pubmed_authors>Pittaway JFH</pubmed_authors><pubmed_authors>Palazzo F</pubmed_authors><pubmed_authors>Ronchi CL</pubmed_authors><pubmed_authors>Sigala S</pubmed_authors><pubmed_authors>Kroiss M</pubmed_authors><pubmed_authors>Abdel-Aziz TE</pubmed_authors><pubmed_authors>Parvanta L</pubmed_authors><pubmed_authors>Lim JA</pubmed_authors><pubmed_authors>Ruiz-Babot G</pubmed_authors><pubmed_authors>Doroszko M</pubmed_authors><pubmed_authors>Foster J</pubmed_authors><pubmed_authors>Rayner O</pubmed_authors><pubmed_authors>Breault DT</pubmed_authors><pubmed_authors>Guasti L</pubmed_authors><pubmed_authors>Altieri B</pubmed_authors><pubmed_authors>Hadjidemetriou I</pubmed_authors><pubmed_authors>Gaston-Massuet C</pubmed_authors><pubmed_authors>Wierman M</pubmed_authors><pubmed_authors>Gomez-Sanchez CE</pubmed_authors><pubmed_authors>Di Marco A</pubmed_authors><pubmed_authors>Drake WM</pubmed_authors><pubmed_authors>Borges KS</pubmed_authors><pubmed_authors>Chung TT</pubmed_authors><pubmed_authors>Rahman N</pubmed_authors><pubmed_authors>Ribeiro C</pubmed_authors><pubmed_authors>Abate A</pubmed_authors><pubmed_authors>Kiseljak-Vassiliades K</pubmed_authors><pubmed_authors>Mariniello K</pubmed_authors><pubmed_authors>Hantel C</pubmed_authors><pubmed_authors>Sosabowski J</pubmed_authors><pubmed_authors>Fassnacht M</pubmed_authors><pubmed_authors>Sbiera S</pubmed_authors><pubmed_authors>Cleaver J</pubmed_authors><pubmed_authors>Taylor DR</pubmed_authors><pubmed_authors>Rognoni E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.</name><description>Disruption of processes involved in tissue development and homeostatic self-renewal is increasingly implicated in cancer initiation, progression, and recurrence. The adrenal cortex is a dynamic tissue that undergoes life-long turnover. Here, using genetic fate mapping and murine adrenocortical carcinoma (ACC) models, we have identified a population of adrenocortical stem cells that express delta-like non-canonical Notch ligand 1 (DLK1). These cells are active during development, near dormant postnatally but are re-expressed in ACC. In a study of over 200 human ACC samples, we have shown DLK1 expression is ubiquitous and is an independent prognostic marker of recurrence-free survival. Paradoxically, despite its progenitor role, spatial transcriptomic analysis has identified DLK1 expressing </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2025-04-22T20:51:24.296Z</modification><creation>2025-04-06T03:20:40.962Z</creation></dates><accession>S-EPMC11370565</accession><cross_references><pubmed>39229217</pubmed><doi>10.1101/2024.08.22.609117</doi></cross_references></HashMap>